Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Recruiting NCT07184957

Prospective Database of Clinical Outcomes Following Cryotherapy for Ablation of Clinically Localized Prostate Cancer

Conditions: Prostate Cancer

Sex: Male
Ages: 40 Years – 85 Years
Healthy volunteers: No
Enrollment: 1000
Sponsor: NYU Langone Health

Location: NYU Langone Health New York New York

Summary

This will be a prospectively maintained research database. The purpose is to record baseline parameters and treatment outcomes following of Cryotherapy for ablation of clinically localized prostate cancer.

Eligibility Criteria

Inclusion Criteria: * Evidence of focal prostate cancer confined to the prostate based on MRI imaging and prostate biopsy * Patients with clinically localized prostate cancer (no evidence for or concern for metastatic spread of cancer outside of the prostate) will be counseled regarding treatment options. Those selecting focal Cryo prostate ablation will then be offered inclusion into this data collection. Exclusion Criteria: * Men that are not diagnosed with prostate cancer. * Men that are diagnosed with clinically localized prostate cancer, but select other treatment options as their desired treatment.

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT07184957). StuddyBuddy aggregates publicly available trial information.